{"id":269407,"date":"2025-01-14T08:05:00","date_gmt":"2025-01-14T12:03:00","guid":{"rendered":"https:\/\/hispanicprwire.com\/english-connecticut-office-of-the-attorney-general-u-s-district-court-grants-preliminary-approval-of-first-settlements-in-multistate-litigation-against-generic-drug-manufacturers-over-conspiracies\/"},"modified":"2025-01-14T09:20:02","modified_gmt":"2025-01-14T13:20:02","slug":"la-corte-del-distrito-de-los-estados-unidos-dio-su-aprobacion-preliminar-de-las-primeras-conciliaciones-en-el-litigio-de-multiples-estados-contra-fabricantes-de-medicamentos-genericos-sobre-conspiraci","status":"publish","type":"post","link":"https:\/\/hispanicprwire.com\/en\/la-corte-del-distrito-de-los-estados-unidos-dio-su-aprobacion-preliminar-de-las-primeras-conciliaciones-en-el-litigio-de-multiples-estados-contra-fabricantes-de-medicamentos-genericos-sobre-conspiraci\/","title":{"rendered":"Connecticut Office of the Attorney General: U.S. District Court Grants Preliminary Approval of First Settlements in Multistate Litigation Against Generic Drug Manufacturers Over Conspiracies to Inflate Prices and Limit Competition"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p><b>If you bought certain generic prescription drugs in <span class=\"xn-location\">the United States<\/span> between <span class=\"xn-chron\">January 1, 2010<\/span> and <span class=\"xn-chron\">December 31, 2018<\/span>, you could be eligible for money<\/b><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">HARTFORD, Conn.<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 14, 2025<\/span><\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;\u00a0Settlements have been reached with some generic prescription drug manufacturers in a lawsuit alleging that consumers paid artificially inflated prices for generic prescription drugs. To date, the Settling Defendants are: Heritage Pharmaceuticals Inc. and\u00a0Emcure Pharmaceuticals Ltd.<\/p>\n<p>The lawsuit continues against all other Non-Settling Defendant drug manufacturers: Actavis, Amneal, Apotex Corp., Ascend, Aurobindo, Bausch, Breckinridge, Citron, Dr. Reddy&#8217;s, Emcure, Fougera (see Sandoz), G&amp;W, Glenmark, Greenstone, Lannett, Lupin, <span class=\"xn-org\">Mallinckrodt<\/span> (bankruptcy), Mayne Pharma, Mylan, Par Pharmaceutical (bankruptcy), Perrigo, Pfizer, Sandoz, Sun, Taro, Teligent (bankruptcy), Teva, Upsher-Smith, Wockhardt, and Zydus.<\/p>\n<p>The lawsuit was brought by many State Attorneys General challenging Defendants with unlawfully agreeing to fix the prices of numerous generic prescription drugs sold in <span class=\"xn-location\">the United States<\/span>. As a result, prescription drug purchasers \u2013 including individual consumers &#8211; may have paid more than was necessary.\u00a0<u>The lawsuit is not about \u2013 and does not question &#8211; the safety or effectiveness of any of the drugs at issue.<\/u><\/p>\n<p>You are included if: (1) you bought a generic prescription drug manufactured by any one of the Defendants; (2) the drug is one of the drugs included in the lawsuit; and (3) your purchase was made within the specified time period for that drug (approximately 2010-2018).\u00a0 A listing of the drugs and a more complete description of eligibility requirements is available at the website (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4338562-2&amp;h=136083773&amp;u=http%3A%2F%2Fwww.aggenericdrugs.com%2F&amp;a=AGGenericDrugs.com\" target=\"_blank\" rel=\"nofollow\">AGGenericDrugs.com<\/a>) or by calling the toll-free number (1-866-290-0182).<\/p>\n<p>The State Attorneys General have created a fund for the deposit of settlement money from current and future settlements (&#8220;Settlement Fund&#8221;).\u00a0 To date, Settling Defendants have agreed to pay <span class=\"xn-money\">$10 million<\/span> into the Settlement Fund, <span class=\"xn-money\">$6 million<\/span> of which is set aside for distribution and <span class=\"xn-money\">$4 million<\/span> of which is set aside to reimburse the State Attorneys General for costs, as well as for expenses and fees, as approved by the Court. Money will not be distributed yet and will be distributed pursuant to a Plan of Allocation approved by the Court at a later date.\u00a0<\/p>\n<p>The State Attorneys General will continue to pursue the lawsuit against the Non-Settling Defendants, with the expectation that additional money from future settlements will be placed into the Settlement Fund for later distribution, including to individual consumers who purchased generic drugs involved in the litigation and who timely submit valid claims.<\/p>\n<p>The claims process will open at a later date.\u00a0 You will need to submit claim form(s) to get a payment, which will be made available to you via the website and other means at a later date.\u00a0 To receive updates about this and future Settlements, including when a claim form is available, and instructions on what information to provide when submitting a claim, you should register on the website, <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4338562-2&amp;h=136083773&amp;u=http%3A%2F%2Fwww.aggenericdrugs.com%2F&amp;a=AGGenericDrugs.com\" target=\"_blank\" rel=\"nofollow\">AGGenericDrugs.com<\/a>,\u00a0or call the toll-free number, 1-866-290-0182.\u00a0\u00a0<\/p>\n<p>If you do nothing, you will be bound by the Settlement and the Court&#8217;s decisions.\u00a0 If you want to keep your right to sue the Settling Defendants, you must exclude yourself (&#8220;Opt out&#8221;) from the Settlement <b>no later than <span class=\"xn-chron\">February 13, 2025<\/span><\/b>.\u00a0 If you wish to file objections or comments\/concerns but still remain in the litigation (and thus be bound by the Settlement and the Court&#8217;s decisions), you may do so by submitting them to the Court in a timely, appropriate manner, as explained on the website,\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4338562-2&amp;h=136083773&amp;u=http%3A%2F%2Fwww.aggenericdrugs.com%2F&amp;a=AGGenericDrugs.com\" target=\"_blank\" rel=\"nofollow\">AGGenericDrugs.com<\/a>.\u00a0 The Court will hold a hearing on <span class=\"xn-chron\">March 7<\/span>, 2025\u00a0to consider whether to approve the current Settlement.\u00a0 You or your own lawyer may appear at the hearing at your own expense, but you do not have to attend.<\/p>\n<p>For more information:<\/p>\n<ul type=\"disc\">\n<li>Visit: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4338562-2&amp;h=653267624&amp;u=http%3A%2F%2Fwww.aggenericdrugs.com%2F&amp;a=www.AGGenericDrugs.com\" target=\"_blank\" rel=\"nofollow\">www.AGGenericDrugs.com<\/a><\/li>\n<li>Call: <b>1-866-290-0182<\/b><\/li>\n<\/ul>\n<p>SOURCE  Connecticut Office of the Attorney General<\/p>\n<\/div>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p><b>If you bought certain generic prescription drugs in <span class=\"xn-location\">the United States<\/span> between <span class=\"xn-chron\">January 1, 2010<\/span> and <span class=\"xn-chron\">December 31, 2018<\/span>, you could be eligible for money<\/b><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">HARTFORD, Conn.<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 14, 2025<\/span><\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;\u00a0Settlements have been reached with some generic prescription drug manufacturers in a lawsuit alleging that&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-269407","post","type-post","status-publish","format-standard","hentry","category-interes-humano"],"acf":[],"_links":{"self":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/269407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/comments?post=269407"}],"version-history":[{"count":"1","href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/269407\/revisions"}],"predecessor-version":[{"id":269408,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/269407\/revisions\/269408"}],"wp:attachment":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media?parent=269407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/categories?post=269407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/tags?post=269407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}